- Environnement et Spermatogenèse
- Published:
Effets d’une exposition à la Vinclozoline et à la Génistéine de la gestation à l’âge adulte sur la fonction de reproduction du ratWistar mâle: protocole et résultats préliminaires
Reproductive effects of chronic exposure (from conception to adulthood) to low concentrations of genistein and vinclozolin in male Wistar rats: protocol and preliminary results
Andrologie volume 13, pages 170–178 (2003)
Resume
Les perturbateurs endocriniens (EDs) présents dans l’environnement sont de plus en plus mis en cause pour expliquer les modifications de la fonction de reproduction mâle, y compris chez l’homme. Cependant, leurs mécanismes d’action sur la fonction de reproduction sont peu connus et le lien de causalité chez l’homme n’est pas démontré. Parmi les nombreuses études expérimentales rapportées, les conditions d’exposition sont le plus souvent très éloignées de la situation environnementale (doses élevées, courtes périodes d’expositon, une seule molécule). Le but de ce projet est d’étudier les effets d’une exposition à deux EDs isolés et associés: la génistéine, phyto-oestrogène et la vinclozoline, fongicide à activité antiandrogénique sur la fonction de reproduction du ratWistar mâle. Pour chaque molécule, 2 doses ont été choisies: une dose élevée et une dose faible compatible avec des expositions environnementales, avec une administration par gavage de la conception à l’âge adulte. Le protocole prévoyait le sacrifice d’une partie des ratons au sevrage et des rats adultes après accouplement, et les examens suivants: pesée des animaux et des organes, réserves spermatiques, histologie des organes de la reproduction et dosage des hormones sexuelles. De plus, une identification plus fine des effets reposera sur la morphométrie testiculaire, l’évaluation de la qualité nucléaire, du mouvement et du degré de fragmentation de l’ADN des spermatozoïdes. A la recherche des mécanismes possiblement en cause, il est prévu d’analyser les récepteurs hormonaux aux oestrogènes, androgènes, progestérone et FSH et d’étudier des modifications de l’apoptose des cellules germinales.
L’élevage des animaux a pu être mené à bien et les premiers résultats ont été:
-
1.
la mise en évidence d’anomalies du développement testiculaire, des vésicules séminales, des épididymes et du pénis observées après exposition à de faible dose pour les composés testés et/ou leur combinaison;
-
2.
une diminution de la mobilité progressive et d’autres paramètres cinétiques observée dès les faibles doses pour les molécules isolées ou associées;
-
3.
une diminution des capacités de reproduction, surtout pour les mâles exposés à la faible dose de vinclozoline et à la combinaison avec la génistéine.
Ces résultats originaux nous incitent maintenant à préciser les effets au niveau tissulaire et cellulaire et à étudier certains des mécanismes possiblement en cause.
Abstract
Current evidence indicates that endocrine disrupters (EDs) can induce adverse effects on the male reproductive tract in various mammalian species. Recent reports indicate deterioration in male reproductive health in several human populations, but the evidence for a causal link with endocrine disruption is still weak. In addition, the experimental conditions of most of the reportedin vivo studies are not representative of environmental exposures (for example, high doses, short-term exposure, a single ED) and the mechanisms by which EDs disrupt the reproductive system are poorly understood. The objective of the present study is to develop an animal model to assess the reproductive effects and study the putative cellular and molecular mechanisms involved after exposure to genistein (phytoestrogen) and vinclozolin (fungicide with a known antiandrogenic potential) alone or in combination. The study will be performed in male Wistar rats, with administration of low and high doses of the compounds from conception to adulthood and a subset of the males in each treatment group will be mated with unexposed females. We plan to assess the level of sperm production, histology of the reproductive organs, motility and morphometry of spermatozoa and hormone levels, as well as DNA fragmentation of spermatozoa and determination of the number of germ cells, Sertoli cells and the diameters of seminiferous tubules. Estrogen, androgen, progesterone and FSH receptors will be detected and quantified and the level of testicular apoptosis and several apoptosis pathways will be studied to determine the putative cellular and molecular mechanisms involved. The preliminary results confirmed the developmental effects previously reported for high doses of vinclozolin. More interestingly, they indicated a number of deleterious effects for male rats exposed to low dosages alone or mixtures of low and high dosages compared to controls and rats exposed to high dosages alone. For example, a number of developmental anomalies of the genitalia were observed and a significant decrease of sperm motility and motion and fertilizing ability were observed. These preliminary results provide evidence that chronic exposure to environmental levels of EDs or mixtures of EDs have a detrimental impact on the male reproductive tract. The next step involves assessment of the anatomical disorders and the study of some of the cellular and molecular mechanisms possibly involved.
References
ADAMI H., BERGSTROM R., MOHNER M., et al.: Testicular cancer in nine northern european countries. Int. J. Cancer, 1994, 59: 33–38.
ADLERCREUTZ H., BANNWART C., WAHALA K., et al.: Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens. J. Steroid. Biochem. Mol. Biol., 1993, 44: 147–153.
AMARAL MENDES J.J.: The endocrine disrupters: a major medical challenge. Food Chem. Toxicol., 2002, 40: 781–788.
AUGER J., KUNSTMANN J.M., CZYGLIK F., JOUANNET P.: Decline in semen quality among fertile men in Paris during the last 20 years. New Engl. J. Med., 1995, 332: 281–285.
BENNETAU-PELISSERO C.: Les phytoestrogènes dans l’alimentation et la thérapie: discussion. Cah. Nutr. Diét., 2001, 36: 25–38.
BILLIG H., FURUTA I., RIVIER C., et al.: Apopotosis in testis germ cells: developmental changes in gonadotropin dependence and localization to selective tubule stages. Endocrinology, 1995, 136, 1: 5–12.
BOOCKFOR F.R., BLAKE C.A.: Chronic administration of 4-tert-octylphenol to adult male rats causes shrinkage of the testes of male accessory sex organs, disrupts spermatogenesis, and increases the incidence of sperm deformities. Biol. Reprod., 1997, 57: 267–277.
BREINHOLT V., HOSSAINI A., SVENDSEN G.W., et al.: Estrogenic activity of flavomoids in mice. The importance of estrogen receptor distribution, metabolism and biovailability. Food Chem. Toxicol., 2000, 38: 555–564.
CARLSEN E., GIWERCMAN A., KEIDING N., SKAKKEBAEK N.E.: Evidence for decreasing quality of semen during past 50 years. Br. Med. J., 1992, 305: 609–613.
DAMGAARD I.N., MAIN K.M., TOPPARI J., SKAKKEBÆK N.E.: Impact of exposure to endocrine disrupters in utero and in childhood on adult reproduction. Baillière’s Best Practice and Research in Clinical Endocrinology and Metabolism, 2002, 16: 289–309.
DASTON G.P., GOOCH J.W., BRESLIN W.J. et al.: Environmental estrogens and reproductive health: a discussion of the human and environmental data. Reprod. Toxicol., 1997, 11: 465–481.
DELCLOS K.B., BUCCI J.C., LOMAX L.G., et al.: Effects of dietary genistein exposure during development on male and female CD [Sprague-Dawley] rats. Reprod. Toxicol., 2001, 15: 647–663.
EUSTACHE F., AUGER J., JOUANNET P.: Effets de deux perturbateurs endocriniens, lap, p’-DDE et le BBP, sur la fonction testiculaire et l’ADN des cellules germinales chez la souris. Hypothèses, 2002, 5: 19–22.
FURUKAWA Y., KIMIJIMA I., ABE R.: Immunohistochemical image analysis of estrogen and progesterone receptors in breast cancer. Breast Cancer, 1998, 25: 375–380.
GILL G.W., SCHUMACHER G.F.B., BIBBO M., et al.: Association of diethylstilbestrol exposure in utero with cryptorchidism, testicular hypoplasia and semen abnormalities. J. Urol., 1979, 122: 36–39.
GOYAL H.O., BRADEN T.D., MANSOUR M., et al.: Diethylstilbestrol-treated adult rats with altered epididymal sperm numbers and sperm motility parameters, but without alterations in sperm production and sperm morphology. Biol. Reprod., 2001, 64: 927–934.
GRAY L.E. Jr.: Xenoendocrine disrupters: laboratory studies on male reproductive effects. Toxicol. Lett., 1998, 102–103: 331–335.
GRAY L.E. Jr, OSTBY J., MONOSSON E., KELCE W.R.: Environmental antiandrogens: low doses of the fungicide vinclozolin alter sexual differentiation of the male rat. Toxicol. Ind. Health, 1999, 15: 48–64.
KELCE W.R., STONE C.R., LAWS S.C., GRAY L.E., KEMPPAINEN J.A., WILSON E.M.: Persistent DDT metabolitep, p’-DDE is a potent androgen receptor antagonist. Nature, 1995, 375 [6532]: 581–585.
KELCE W.R., LAMBRIGHT C.R., GRAY L.E. Jr, ROBERTS K.P.: Vinclozolin andp, p’-DDE alter androgen-dependent gene expression:in vivo confirmation of an androgen receptor-mediated mechanism. Toxicol. Appl. Pharmacol., 1997, 142: 192–200.
KIM E.D., LIN W.W., ABRAMS J., LIPSHULTZ L.I.: Testis biopsy image analysis effectively quantifies spermatogenetic cell types. J. Urol., 1997, 157: 147–150.
KLIP H., VERLOOP J., VAN GOOL J.D., KOSTER M.E.T.A., BURGER C.W., VAN LEEUWEN F.E.: Hypospadias in sons of women exposed to diethylstilbestrolin utero: a cohort study. Lancet, 2002, 359: 1102–1107.
LUCONI M., FORTI G., BALDI E.: Genomic and nongenomic effects of estrogens: molecular mechanisms of action and clinical implications for male reproduction. J. Steroid. Biochem. Mol. Biol., 2002, 80: 369–381.
MONOSSON E., KELCE W.R., LAMBRIGHT C., et al.: Peripubertal exposure to the antiandrogenic fungicide, vinclozolin, delays puberty, inhibits the development of androgen-dependent tissues, and alters androgen receptor function in the male rat. Toxicol. Ind. Health, 1999, 15: 65–79.
OKAHARA A., NOMURA A., TANIOKA H., et al.: Collaborative work to evaluate toxicity on male reproductive organs by repeated dose studies in rats: effects of repeated doses of flutamide for 2 and 4 weeks. J. Toxicol. Science, 2000, 25: 63–70.
PAULOZZI L.J., ERICKSON D., JACKSON R.J.: Hypospadias trends in two US surveillance systems. Pediatrics, 1997, 100: 831–834.
PELLETIER G.: Localization of androgen and estrogen receptors in rat and primate tissues. Histol. Histopathol., 2000, 15: 1261–1270.
PETRELLI G., MANTOVANI A.: Environmental risk factors and male fertility and reproduction. Contraception, 2002, 65: 297–300.
SANDERSON J.T., BOERMA J., GIDEON W.A. et al.: Induction and inhibition of aromatase [CYP19] activity by various classes of pesticides in H295R human adrenocortical carcinoma cells. Toxicol. Appl. Pharmacol., 2002, 182: 44–54.
SANTTI R., MÄKELÄ S., STRAUSS L. et al.: Phytoestrogens: potential endocrine disruptors in males. Toxicol. Ind. Health, 1998, 14: 223–237.
SHARPE R.M.: Environmental oestrogens and male infertility. Pure Appl. Chem., 1998, 70: 1685–1701.
SHARPE R.M.: The ‘oestrogen hypothesis’ — where do we stand now? Int. J. Androl., 2003, 26: 2–15.
SHETTY J., MARATHE G.K., DIGHE R.R.: Specific immunoneutralization of FSH leads to apoptotic cell death of the pachytene spermatocytes and spermatogonial cells in the rat. Endocrinology, 1996, 137: 2179–2182.
SHIBAYAMA T., FUKATA H., SAKURAI K. et al.: Neonatal exposure to genistein reduces expression of estrogen receptor alpha and androgen receptor in testes of adult mices. Endoc. J., 2001, 48: 655–663.
SINHA HIKIM A.P., RAJAVASHISTH T.B., SINHA HIKIM I. et al.: Significance of apoptosis in the temporal and stage-specific loss of germ cells in the adult rat after gonadotrophin deprivation. Biol. Reprod., 1997, 57: 1193–1201.
SWANN S.H., ELKIN E.P., FENSTER L.: Have sperm densities declined? A reanalysis of global trend data. Environ. Health Perspec., 1997, 105: 1228–1232.
TEILMANN G., JUUL A., SKAKKEBAEK N.E., TOPPARI J.: Putative effects of endocrine disrupters on pubertal development in the human. Best Practice Res. Clin. Endocrinol. Metab., 2002, 16, 105–121.
TOPPARI J., LARSEN J.C., CHRISTIANSEN P. et al.: Male reproductive health and environmental xenoestrogens. Environ. Health Perspect., 1996, 104, Suppl 4, 741.
TOPPARI J., KAVELA M., VIRTAINEN H.E.: Trends in the incidence of cryptorchidism and hypospadias and methodological limitations of registry-based data. Hum. Reprod. Update, 2001, 7: 282–286.
VERDEAL K., RYAN R.S.: Naturally occuring estrogens in plant foodstuffs. A review. J. Food Protect., 1979, 42: 577–583.
WEBER K.B., SETCHELL K.D.R., STOCCO D.M., LEPHART E.D.: Dietary soy-phytoestrogens decrease testosterone levels and prostate weight without altering LH, prostate 5a-reductase or testicular steroidogenic accute regulatory peptide levels in adult male Sprague-Dawley rats. J. Endocrinol., 2001, 170: 591–599.
WOLF C.J., LEBLANC G.A., OSTBY J.S., GRAY L.E., Jr.: Characterization of the period of sensitivity of fetal male sexual development to vinclozolin. Toxicol. Sciences, 2000, 55: 152–161.
WILLIAMS K., FISHER J.S., TURNER K.J., et al.: Relationship between expression of sex steroid receptors and structure of the seminal vesicles after neonatal treatment of rats with potent or weak estrogens. Environ. Health Perspect., 2001, 109: 1227–1235.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Eustache, F., Lesaffre, C., Cannivenc, M.C. et al. Effets d’une exposition à la Vinclozoline et à la Génistéine de la gestation à l’âge adulte sur la fonction de reproduction du ratWistar mâle: protocole et résultats préliminaires. Androl. 13, 170–178 (2003). https://doi.org/10.1007/BF03034432
Issue Date:
DOI: https://doi.org/10.1007/BF03034432
Mots clés
- perturbateurs endocriniens
- faible dose
- association
- appareil génital mâle
- fertilité
- spermatozoïdes
Key-Words
- endocrine disrupters
- low dosage
- mixtures
- male fertility
- reproductive tract
- spermatozoa